Please join us in welcoming industry veteran, Fred B. Davenport, Jr. to our Board of Directors! As an independent director, Fred brings a significant pedigree in scaling global organizations within the CRO industry, having spent 10 years at Pharmaceutical Product Development, Inc. (PPD) during its rapid growth phase, followed by 6 years on the Board of Directors for Medpace, Inc.
At PPD, Fred served in various roles, including General Counsel, Executive Vice President, and President. During that time, he was responsible for global operations and numerous support functions, including Phase 1-4 clinical operations in the Americas, Europe, and Asia, global laboratory services, quality management, intellectual technology, strategic development, human resources, facilities, purchasing, and legal.
As a partner with Murchison, Taylor & Gibson, PLLC in Wilmington, NC, Fred now focuses his legal practice on mergers and acquisitions and general corporate representation.
“We are incredibly excited about Fred joining our Board as we plan for the next phase of our growth and development. In our industry, few have the hands-on experience of scaling a company to the levels Fred has achieved. We look forward not only to his operational guidance, but also his M&A expertise as we begin to deploy fresh capital.”
– Jeff Williams, CEO, Clinipace Worldwide
Click here to read today’s full announcement.